Cobra's Cell Line Development Tech Bags Recopharma Contract
As Cobra wins a cell line development contract with Recopharma, the firm says its cost-effective gene expression technology has been its biggest growth area.
Archives for May 28, 2013
US FDA Recommends CMO Quality Agreements in Long-Awaited Draft Guidance
Although written quality agreements are not required under cGMP regulations, the US FDA is recommending that pharma companies and CMOs adopt the agreements to delineate responsibilities.
Newcastle Uni Develops Skin Test That Predicts Reaction to New Drugs
Scientists at the UK University have developed what they refer to as 'a simple lab-based skin test' which eliminates the risk of adverse reactions to new drugs, cosmetics, and household chemicals.
Clinical Investigator Hit with US FDA Warning Letter for Falsified Data
The US FDA has sent a warning letter to a clinical investigator after he failed to take adequate action on falsified data in a study he oversaw.
Lilly Adds Another to List of Companion Diagnostic Contractors
Eli Lilly has selected another contractor to help develop companion diagnostics for its oncology pipeline.
DISPATCHES FROM INTERPHEX
Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use
Over the last decade single-use technologies have moved into manufacturing scales and are increasingly being deployed worldwide, according to Thermo Fisher Scientific.